{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:08:37Z","timestamp":1760551717410},"reference-count":7,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"DOI":"10.25259\/ijdvl_193_2022","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T12:17:44Z","timestamp":1654949864000},"page":"664-666","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sweet syndrome induced by epidermal growth factor receptor (EGFR) inhibitors"],"prefix":"10.25259","volume":"88","author":[{"given":"Christina MT","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua JX","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edric CC","family":"IP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes WS","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"10.25259\/IJDVL_193_2022\/ref-1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1365-2133.2006.07452.x","article-title":"The PRIDE (Papulopustules and\/or paronychia, regulatory abnormalities of hair growth, itching, and dryness due to epidermal growth factor receptor inhibitors) syndrome","volume":"155","author":"Lacouture","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_193_2022\/ref-2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40257-022-00673-4","article-title":"New practical aspects of sweet syndrome","author":"Joshi","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.25259\/IJDVL_193_2022\/ref-3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0738-081x(99)00124-8","article-title":"Neutrophilic drug eruptions","volume":"18","author":"Roujeau","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.25259\/IJDVL_193_2022\/ref-4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet\u2019s syndrome \u2013 a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.25259\/IJDVL_193_2022\/ref-5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.25259\/IJDVL_193_2022\/ref-6","doi-asserted-by":"publisher","first-page":"10182","DOI":"10.1096\/fj.201902922RR","article-title":"Erlotinib is effective against FLT3-ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn","volume":"34","author":"Cao","year":"2020","journal-title":"FASEB J"},{"key":"10.25259\/IJDVL_193_2022\/ref-7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc1970","article-title":"Mechanisms of cutaneous toxicities to EGFR inhibitors","volume":"6","author":"Lacouture","year":"2006","journal-title":"Nat Rev Cancer"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/sweet-syndrome-induced-by-epidermal-growth-factor-receptor-egfr-inhibitors\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/sweet-syndrome-induced-by-epidermal-growth-factor-receptor-egfr-inhibitors\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T11:52:30Z","timestamp":1679313150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/sweet-syndrome-induced-by-epidermal-growth-factor-receptor-egfr-inhibitors\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":7,"alternative-id":["10.25259\/IJDVL_193_2022"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_193_2022","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"article-number":"664"}}